News

As in the SMART trial, early hemodynamic differences have yet to result in a clinical impact—but it may just be a matter of ...
The FDA gave the OK for the North Chicago-based medical device maker's Tendyne transcatheter mitral valve replacement.
The system is available for patients whose mitral valves are not working properly due to severe mitral annular calcification.
The FDA approved Abbott's Tendyne minimally invasive heart replacement for mitral valve disease that could disqualify ...
Abbott (NYSE: ABT) announced today that it received FDA approval for its Tendyne transcatheter mitral valve replacement (TMVR ...
Looking toward approval in the US, larger studies with careful hemodynamic data will be needed, says Martin Leon.
This week, a number of companies, big and small, shared updates on their cardiovascular technology innovations at EuroPCR ...
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else ...
Sanitube’s sanitary steel products are an essential link in the supply chain that gets milk, cheese, and other foods to your ...
They call it a money shift because making this mistake with your manual transmission can cost you big bucks. But what does it ...
Re-planting could see the complete refurbishment of up to all six generating units at Dinorwig - a final investment decision ...